PL230115A1 - - Google Patents

Info

Publication number
PL230115A1
PL230115A1 PL23011581A PL23011581A PL230115A1 PL 230115 A1 PL230115 A1 PL 230115A1 PL 23011581 A PL23011581 A PL 23011581A PL 23011581 A PL23011581 A PL 23011581A PL 230115 A1 PL230115 A1 PL 230115A1
Authority
PL
Poland
Prior art keywords
acid
sup
compounds
unsubstituted
formulawhere
Prior art date
Application number
PL23011581A
Other languages
English (en)
Other versions
PL129094B1 (en
Inventor
Lionel N Simon
Alfredo Giner-Sorolla
Alvin Guttag
Original Assignee
Newport Pharmaceuticals
Sloan Kettering Inst Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newport Pharmaceuticals, Sloan Kettering Inst Cancer filed Critical Newport Pharmaceuticals
Publication of PL230115A1 publication Critical patent/PL230115A1/xx
Publication of PL129094B1 publication Critical patent/PL129094B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28Oxygen atom
    • C07D473/30Oxygen atom attached in position 6, e.g. hypoxanthine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL1981230115A 1980-03-14 1981-03-12 Process for preparing derivatives of hydroxyalkylpurines PL129094B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/130,334 US4340726A (en) 1980-03-14 1980-03-14 Esters

Publications (2)

Publication Number Publication Date
PL230115A1 true PL230115A1 (cg-RX-API-DMAC7.html) 1981-11-13
PL129094B1 PL129094B1 (en) 1984-03-31

Family

ID=22444200

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1981230115A PL129094B1 (en) 1980-03-14 1981-03-12 Process for preparing derivatives of hydroxyalkylpurines

Country Status (26)

Country Link
US (1) US4340726A (cg-RX-API-DMAC7.html)
EP (1) EP0036077B1 (cg-RX-API-DMAC7.html)
JP (1) JPS572287A (cg-RX-API-DMAC7.html)
KR (1) KR850000320B1 (cg-RX-API-DMAC7.html)
AT (1) ATE8995T1 (cg-RX-API-DMAC7.html)
AU (1) AU535052B2 (cg-RX-API-DMAC7.html)
CA (1) CA1159827A (cg-RX-API-DMAC7.html)
CS (1) CS235514B2 (cg-RX-API-DMAC7.html)
DD (1) DD156813A5 (cg-RX-API-DMAC7.html)
DE (1) DE3165476D1 (cg-RX-API-DMAC7.html)
DK (1) DK154768C (cg-RX-API-DMAC7.html)
ES (1) ES8202825A1 (cg-RX-API-DMAC7.html)
FI (1) FI67848C (cg-RX-API-DMAC7.html)
GR (1) GR74807B (cg-RX-API-DMAC7.html)
HU (1) HU187324B (cg-RX-API-DMAC7.html)
IE (1) IE51019B1 (cg-RX-API-DMAC7.html)
IL (1) IL62258A (cg-RX-API-DMAC7.html)
IN (1) IN155441B (cg-RX-API-DMAC7.html)
NO (1) NO155579C (cg-RX-API-DMAC7.html)
NZ (1) NZ196295A (cg-RX-API-DMAC7.html)
PH (1) PH19148A (cg-RX-API-DMAC7.html)
PL (1) PL129094B1 (cg-RX-API-DMAC7.html)
PT (1) PT72665B (cg-RX-API-DMAC7.html)
RO (1) RO82509A (cg-RX-API-DMAC7.html)
YU (1) YU41973B (cg-RX-API-DMAC7.html)
ZA (1) ZA811181B (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4423050A (en) * 1981-05-21 1983-12-27 Syntex (U.S.A.) Inc. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
JPS58135878A (ja) * 1981-09-22 1983-08-12 Suntory Ltd 新規アイラントン誘導体及びその製造法
AU564576B2 (en) * 1981-09-24 1987-08-20 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Purine derivatives
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds
US4609662A (en) * 1982-10-14 1986-09-02 Burroughs Wellcome Co. Method for using purine derivatives
HUT36464A (en) * 1983-05-24 1985-09-30 Newport Pharmaceuticals Process for producing erythro-4-amino-3-/2-hydroxy-3-alkyl/-imidazol-5-carboxamide
JP3005959B2 (ja) * 1989-03-31 2000-02-07 ヤンマー農機株式会社 乗用田植機における植付部伝動構造
US5614504A (en) * 1990-08-01 1997-03-25 The University Of South Florida Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
US6420374B1 (en) 1990-11-30 2002-07-16 Fred Hutchinson Cancer Research Center Use of xanthines as immunosuppressants and to inhibit allograft reactions
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
BE1008977A5 (fr) * 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
US6303617B1 (en) 1998-05-04 2001-10-16 Neotherapeutics, Inc. Serotonin-like 9-substituted hypoxanthine and methods of use
US6297226B1 (en) 1999-10-15 2001-10-02 Neotherapeutics, Inc. Synthesis and methods of use of 9-substituted guanine derivatives
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
ATE499103T1 (de) 2000-07-07 2011-03-15 Spectrum Pharmaceuticals Inc Verfahren zur behandlung von arzneimittelinduzierter peripherer neuropathie und verwandten krankheitsformen
US6759427B2 (en) 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
CA2540598C (en) * 2003-10-03 2013-09-24 3M Innovative Properties Company Pyrazolopyridines and analogs thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2940966A (en) * 1958-05-15 1960-06-14 Daniel R Bullard Glucoside of 2-amino-4-hydroxy-6-(1', 2'-dihydroxypropyl)-pteridine
US3862189A (en) * 1973-08-14 1975-01-21 Warner Lambert Co Aralkyl-substituted purines and pyrimidines as antianginal bronchodilator agents
US4138562A (en) * 1977-02-09 1979-02-06 The Regents Of The University Of Minnesota Adenosine deaminase resistant antiviral purine nucleosides and method of preparation
DE2714883A1 (de) * 1977-04-02 1978-10-12 Basf Ag Nicht-glykosidische theophyllin- zucker-derivate
JPS55113786A (en) * 1979-02-23 1980-09-02 Toyo Jozo Co Ltd Novel substance, nepranosin b or f and its preparation
US4221909A (en) * 1978-09-15 1980-09-09 Sloan-Kettering Institute For Cancer Research P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines
US4221910A (en) * 1978-09-15 1980-09-09 Newport Pharmaceuticals International, Inc. 9-(Hydroxy alkyl)purines
US4221794A (en) * 1979-06-21 1980-09-09 Newport Pharmaceuticals International, Inc. Method of imparting immunomodulating and antiviral activity

Also Published As

Publication number Publication date
KR850000320B1 (ko) 1985-03-20
NO810723L (no) 1981-09-15
IE810552L (en) 1981-09-14
DK154768B (da) 1988-12-19
AU6802581A (en) 1981-09-17
PH19148A (en) 1986-01-15
IL62258A (en) 1984-12-31
DE3165476D1 (en) 1984-09-20
EP0036077A3 (en) 1982-01-13
CS235514B2 (en) 1985-05-15
FI67848B (fi) 1985-02-28
ZA811181B (en) 1982-01-27
ES500321A0 (es) 1982-03-01
JPH031311B2 (cg-RX-API-DMAC7.html) 1991-01-10
RO82509A (ro) 1983-09-26
JPS572287A (en) 1982-01-07
EP0036077A2 (en) 1981-09-23
GR74807B (cg-RX-API-DMAC7.html) 1984-08-12
FI810774L (fi) 1981-09-15
CA1159827A (en) 1984-01-03
US4340726A (en) 1982-07-20
ATE8995T1 (de) 1984-09-15
YU41973B (en) 1988-04-30
ES8202825A1 (es) 1982-03-01
KR830005224A (ko) 1983-08-03
PT72665A (en) 1981-04-01
DK154768C (da) 1989-06-19
NZ196295A (en) 1983-09-02
HU187324B (en) 1985-12-28
NO155579C (no) 1987-04-22
NO155579B (no) 1987-01-12
EP0036077B1 (en) 1984-08-15
DK115081A (da) 1981-09-15
IN155441B (cg-RX-API-DMAC7.html) 1985-02-02
RO82509B (ro) 1983-08-30
PL129094B1 (en) 1984-03-31
IE51019B1 (en) 1986-09-03
AU535052B2 (en) 1984-03-01
DD156813A5 (de) 1982-09-22
PT72665B (en) 1982-06-08
YU65181A (en) 1984-02-29
FI67848C (fi) 1985-06-10

Similar Documents

Publication Publication Date Title
PL230115A1 (cg-RX-API-DMAC7.html)
GB1512541A (en) Aralkyl carboxylic acid compounds
ES465291A1 (es) Procedimiento para preparar esteres de acidos ciclopropano- carboxilicos con alcoholes bencilicos halogenados.
WO1991004754A3 (en) Illudin analogs as anti-tumor agents
NZ211954A (en) Reaction products of alkenylsuccinic acid, esters or anhydrides with aromatic amines and lubricant compositions thereof
DE2860449D1 (en) Use of acid esters of phosphoric acids and alkoxylated aliphatic polyols as corrosion inhibitors and lubricants
ES8107306A1 (es) Un metodo mejorado para producir y acumular el antibiotico c-15003 p-3
IE821738L (en) Ml-236b derivatives
GB1268008A (en) ESTERS OF p-BYPHENYLYLACETIC ACID
EP0220892A3 (en) Cold flow improving fuel additive compound and fuel composition containing same
DE3681952D1 (de) Phenolveresterung, katalysiert durch phosphoriger saeure.
AU680325B2 (en) Process for the carbonylation of an acetylenically unsaturated compound
JPS5396085A (en) Fatty acid esterified mannanphosphoric acid
JPS5661377A (en) Optically active cephaloasporin analog
GB1252701A (cg-RX-API-DMAC7.html)
ES326105A1 (es) Un metodo de producir acido glutanico.